Cognitive impairment following stroke
https://doi.org/10.14412/2074-2711-2025-6-120-126
Abstract
Stroke is one of the leading causes of death and disability worldwide. Post-stroke cognitive impairment (PSCI), characterised as a decline in cognitive function following a stroke, can range from mild deficits to dementia and is a common and serious long-term consequence of stroke. CI can develop after both ischemic and hemorrhagic strokes. The risk and timing of PSCI may depend on various factors. The presence of PSCI is independently associated with a lower quality of life after stroke and higher mortality. Understanding the pathogenesis of PSCI is fundamental to reducing the global burden of stroke. Treatment of PSCI involves a multidisciplinary approach to addressing the underlying causes and cognitive symptoms. Management strategies focus on cognitive rehabilitation, pharmacological interventions, and the elimination of modifiable risk factors.
Keywords
ischemic and hemorrhagic stroke,
cognitive impairment,
risk factors,
pathophysiology,
therapeutic approaches
Supporting agencies: The article is sponsored by Ozon
About the Authors
N. V. Pizova
Yaroslavl State Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Competing Interests:
The conflict of interests did not affect the results of the study
A. V. Pizov
Yaroslavl State Pedagogical University named after K.D. Ushinsky
Russian Federation
Competing Interests:
Russian Federation
Department of Methods of teaching Natural Sciences and Mathematics in primary schools.
108/1, Respublikanskaya St., Yaroslavl 150000
Competing Interests:
The conflict of interests did not affect the results of the study
References
1. Feigin VL, Brainin M, Norrving B, et al. World Stroke Organization: Global Stroke Fact Sheet 2025. Int J Stroke. 2025;20(2):132-44. doi: 10.1177/17474930241308142
2. Gong L, Yao YY, Wang Y. Investigation on the survival status and traditional Chinese medicine characteristics of ischemic stroke patients of different genders. J Integr Tradit Chin West Med Cardio-Cerebrovasc Dis. 2020;18(15):2404-9. doi: 10.12102/j.issn.1672-1349.2020.15.007
3. Obaid M, Douiri A, Flach C, et al. Can we prevent poststroke cognitive impairment? An umbrella review of risk factors and treatments. BMJ Open. 2020;10(9):e037982. doi: 10.1136/bmjopen-2020-037982
4. El Husseini N, Katzan IL, Rost NS, et al. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the american heart association/american stroke association. Stroke. 2023;54(6):e272e291. doi: 10.1161/STR.0000000000000430
5. Munthe-Kaas R, Aam S, Ihle-hansen H, et al. Impact of different methods defining poststroke neurocognitive disorder: The Nor-COAST study. Alzheimers Dement. 2020;6(1):e12000. doi: 10.1002/trc2.12000
6. Sachdev PS, Brodaty H, Valenzuela MJ, et al. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney stroke study. Dement Geriatr Cogn Disord. 2006;21(5-6):275-83. doi: 10.1159/000091434
7. Sexton E, McLoughlin A, Williams DJ, et al. Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke. Eur Stroke J. 2019;4:160-71. doi: 10.1177/2396987318825484
8. Verbitskaya SV, Parfenov VA, Reshetnikov VA, et al. Post-stroke cognitive impairment (results of a 5-year follow-up). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):37-42 (In Russ.). doi: 10.14412/2074-2711-2018-1-37-42
9. Delavaran H, Jönsson A, Lövkvist H, et al. Cognitive function in stroke survivors: a 10-year follow-up study. Acta Neurol Scand. 2017;136(3):187-94. doi: 10.1111/ane.12709
10. Brewer L, Mellon L, Hall P, et al. Secondary prevention after ischaemic stroke: the ASPIRE-S study. BMC Neurol. 2015;15:216. doi: 10.1186/s12883-015-0466-2
11. Jia WL, Liu Q, Li SQ. Correlation between hemoglobin level at admission and post-stroke cognitive impairment in acute stroke patients. China Acad J. 2021;56(12):1346-9. doi: 10.3969/j.issn.1008-1070.2021.12.020
12. Gallucci L, Sperber C, Guggisberg AG, et al. Post-stroke cognitive impairment remains highly prevalent and disabling despite state-of-the-art stroke treatment. Int J Stroke. 2024;19(8):888-97. doi: 10.1177/17474930241238637
13. Dec-Cwiek M, Wrona P, Homa T, et al. Incidence and Factors Associated With Cognitive Impairment 90 Days After First Ever Ischemic Stroke. Int J Geriatr Psychiatry. 2025;40(5):e70087. doi: 10.1002/gps.70087
14. Moulin S, Labreuche J, Bombois S, et al. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol. 2016;15:820-9. doi: 10.1016/S14744422(16)00130-7
15. Mayer SA, Kreiter KT, Copeland D, et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology. 2002;59:1750-8. doi: 10.1212/01.wnl.0000035748.91128.c2
16. Springer MV, Schmidt JM, Wartenberg KE, et al. Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery. 2009;65:1043-50. doi: 10.1227/01.NEU.0000359317.15269.20
17. Pizova NV, Pizov AV. Ischemic stroke in men and women at different age periods. Poliklinika. 2025;(1-3):9-12 (In Russ.). Available at: https://poliklin.ru/pdf/2025/Nevro_Kardio_Zh DA_1_2025_obsh_fin+.pdf
18. Weterings RP, Kessels RP, de Leeuw FE, Piai V. Cognitive impairment after a stroke in young adults: A systematic review and metaanalysis. Int J Stroke. doi: 10.1177/17474930231159267
19. Rodriguez Garcia PL, Rodriguez Garcia D. Diagnosis of vascular cognitive impairment and its main categories. Neurologia. 2015;30:223-39. doi: 10.1016/j.nrl.2011.12.014
20. Lo JW, Crawford JD, Desmond DW, et al. Long-term cognitive decline after stroke: an individual participant data meta-analysis. Stroke. 2022;53(4):1318-27. doi: 10.1161/STROKEAHA.121.035796
21. Contador I, Alzola P, Bermejo-Pareja F, et al. Education and literacy as risk factors of dementia after stroke and transient ischemic attack: nedices study. J Alzheimers Dis. 2022;88(1):291-9. doi: 10.3233/JAD-220109
22. Weaver AN, Jaeggi SM. Activity engagement and cognitive performance amongst older adults. Front Psychol. 2021:12:620867. doi: 10.3389/fpsyg.2021.620867
23. Rost NS, Meschia JF, Gottesman R, et al. Cognitive impairment and dementia after stroke: design and rationale for the discovery study. Stroke. 2021;52(8):e499-e516. doi: 10.1161/STROKEAHA.120.031611
24. Elendu C, Amaechi DC, Elendu TC, et al. Stroke and cognitive impairment: understanding the connection and managing symptoms. Ann Med Surg (Lond). 2023;85(12):6057-66. doi: 10.1097/MS9.0000000000001441
25. Rajan KB, Aggarwal NT, Schneider JA, et al. Role of apoe E4 allele and incident stroke on cognitive decline and mortality. Alzheimer Dis Assoc Disord. 2016;30(4):318-23. doi: 10.1097/WAD.0000000000000173
26. Weaver NA, Kuijf HJ, Aben HP, et al. Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts. Lancet Neurol. 2021;20(6):448-59. doi: 10.1016/S1474-4422(21)00060-0
27. Koton S, Pike JR, Johansen M, et al. Association of ischemic stroke incidence, severity, and recurrence with dementia in the Atherosclerosis Risk in Communities cohort study. JAMA Neurol. 2022;79:271-80. doi: 10.1001/jamaneurol.2021.5080
28. Pendlebury ST, Rothwell PM; Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the populationbased Oxford Vascular Study. Lancet Neurol. 2019;18:248-58. doi: 10.1016/S1474-4422(18)30442-3
29. Drozdowska BA, Elliott E, Taylor-Rowan M, et al. Cardiovascular risk factors indirectly affect acute post-stroke cognition through stroke severity and prior cognitive impairment: a moderated mediation analysis. Alzheimers Res Ther. 2020;12(1):85. doi: 10.1186/s13195-02000653-y.
30. Levine DA, Chen B, Galecki AT, et al. Associations between vascular risk factor levels and cognitive decline among stroke survivors. IAMA Netw Open. 2023;6(5):e2313879. doi: 10.1001/jamanetworkopen.2023.13879
31. Shang Y, Fratiglioni L, Marseglia A, et al. Association of diabetes with stroke and poststroke dementia: a population-based cohort study. Alzheimers Dement. 2020;16(7):1003-12. doi: 10.1002/alz.12101
32. Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62(5):810-7. doi: 10.1161/HYPERTENSIONAHA.113.01063
33. Peh A, O'Donnell JA, Broughton BRS, Marques FZ. Gut microbiota and their metabolites in stroke: a double-edged sword. Stroke. 2022;53(5):1788-801. doi: 10.1161/STROKEAHA.121.036800
34. Goralczyk-Binkowska A, Szmajda-Krygier D, Kozlowska E. The microbiota-gut-brain axis in psychiatric disorders. Int J Mol Sci. 2022;23(19):11245. doi: 10.3390/ijms231911245
35. Zhou W, Feng H, Tao H, et al. Factors Influencing Poststroke Cognitive Dysfunction: Cross-Sectional Analysis. JMIR Form Res. 2024;8:e59572. doi: 10.2196/59572
36. Cerasuolo JO, Mandzia J, Cipriano LE, et al. Intravenous thrombolysis after first-ever ischemic stroke and reduced incident dementia rate. Stroke. 2022;53(4):1170-7. doi: 10.1161/STROKEAHA.121.034969
37. Jokinen H, Melkas S, Ylikoski R, et al. Poststroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015;22(9):1288-94. doi: 10.1111/ene.12743
38. Xu G, Dong X, Niu X, et al. Cognitive function and prognosis of multimodal neuroimage-guided thrombectomy on mild to moderate anterior circulation infarction patients with broadened therapeutic window: A prospective study. Eur Neurol. 2017;78:257-63. doi: 10.1159/000479735
39. De Rubeis G, Ghozy S, Fabiano S, et al. The Effect of Mechanical Thrombectomy on the Incidence of Poststroke Cognitive Impairment: A Systematic Review of Inhomogeneous Literature. Cerebrovasc Dis. 2023;52(6):711-9. doi: 10.1159/000529265
40. Lattanzi S, Coccia M, Pulcini A, et al. Endovascular treatment and cognitive outcome after anterior circulation ischemic stroke. Sci Rep. 2020;10(1):18524. doi: 10.1038/s41598020-75609-1
41. Silva GS, Lima FO, Camargo EC, et al. Gender differences in outcomes after ischemic stroke: Role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc Dis. 2010;30(5):470-5. doi: 10.1159/000317088
42. Bonkhoff AK, Karch A, Weber R, et al. Sex differences in acute treatment and early outcomes of acute ischemic stroke. Stroke. 2021;52(2):406-15. doi: 10.1161/STROKEAHA.120.032850
43. Gall S, Phan H, Madsen TE, et al. Focused update of sex differences in patient reported outcome measures after stroke. Stroke. 2018;49(3):531-5. doi: 10.1161/STROKEAHA.117.018417
44. Yu J, Wang J. Effect of post-stroke cognitive impairment and dementia on stroke recurrence and functional outcomes: A systematic review and meta-analysis. PLoS One. 2024;19(12):e0313633. doi: 10.1371/journal.pone.0313633
45. Cicerone KD, Goldin Y, Ganci K, et al. Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014. Arch Phys Med Rehabil. 2019;100:1515-33. doi: 10.1016/j.apmr.2019.02.011
46. Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a metaanalysis of randomised controlled trials. Lancet Neurol. 2007;6:782-92. doi: 10.1016/S14744422(07)70195-3
47. Battle CE, Abdul-Rahim AH, Shenkin SD, et al. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database Syst Rev. 2021;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2
48. Swiatkiewicz M, Grieb P. Citicoline for Supporting Memory in Aging Humans. Aging Dis. 2023;14(4):1184-95. doi: 10.14336/AD.2022.0913
49. Gareri P, Castagna A, Cotroneo AM, et al. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages and doubts for an old drug with new perspectives. Clin Interv Aging. 2015;10:1421-9. doi: 10.2147/CIA.S87886
50. Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2022 update. Rev Neurol. 2022;75(5):S1-S89. doi: 10.33588/rn.75s05.2022311
51. Jasielski P, Piedel F, Piwek M, et al. Application of citicoline in neurological disorders: a systematic review. Nutrients. 2020;12(10):3113. doi: 10.3390/nu12103113
52. Fioravanti M, Yanagi M. Cytidinediphospho choline (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005;(2):CD000269.
53. Cotroneo AM, Castagna A, Putignano S, et al. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin Interv Aging. 2013:8:131-7. doi: 10.2147/CIA.S38420
54. Alvarez-Sabin J, Santamarina E, Maisterra O, et al. Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. Int J Mol Sci. 2016;17:390. doi: 10.3390/ijms17030390
55. Bermejo PE, Dorado R, Ascension Zea-Sevilla M. Role of Citicoline in Patients With Mild Cognitive Impairment. Neurosci Insights. 2023:18:26331055231152496. doi: 10.1177/26331055231152496
56. Bogolepova AN, Burd SG, Lebedeva AV, Kovalenko EA. Experience with citicoline in patients with post-stroke cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):43-8 (In Russ.). doi: 10.14412/20742711-2020-4-43-48
57. Gareri P, Castagna A. Citicoline in vascular cognitive impairment. Some latest evidences. Ann Alzheimers Dement Care. 2017;2(1):18-9. doi: 10.17352/aadc.000004
58. Shchepankevich LA, Gribacheva IA, Popova TF, et al. Clinical experi ence with the use of citicoline in mild cognitive impairment of vascular origin. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(4):749 (In Russ.). doi: 10.14412/2074-2711-2023-4-74-79
59. Shchepankevich LA, Rerikh KV, Ponomareva MS, et al. Asthenia and vascular cognitive impairment in young patients after stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(5):69-76 (In Russ.). doi: 10.14412/2074-2711-2024-5-69-76
Review
For citations:
Pizova NV, Pizov AV. Cognitive impairment following stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2025;17(6):120-126. (In Russ.) https://doi.org/10.14412/2074-2711-2025-6-120-126
Views:
52
Email this article 